As global shortages hit Ozempic and Wegovy, rivals like Eli Lilly gain ground, including in India’s growing market for ...

Locally produced versions of drugs like Semaglutide are helpful for patients with obesity and diabetes, but unprescribed use raises concerns ...

After four days of deadly fighting between India and Pakistan that seemed near the edge of catastrophe, the two sides abruptly agreed to a U.S.-brokered cease-fire on Saturday. The conflict began ...

Additional highlights include powered rear-sliding doors and rear entertainment screens. MG Motor India first showcased the MG M9 luxury electric MPV at the 2025 Bharat Mobility Expo. And now the ...

Rakesh Sen, Head of Sales, JSW MG Motor India said, "The introduction of the E20-compliant version demonstrates in no uncertain terms our commitment to innovation and sustainability in everything we ...

That said, here is everything we can expect from the India-spec M9: The MG M9 is an electric luxury MPV that will be sold via the carmaker’s premium ‘MG Select’ outlets alongside the MG ...

With over 20,000 unit sales since its launch in September 2024, the Windsor EV has become the fastest EV in India to cross the sales mark Since its launch in September 2024, the MG Windsor EV has ...

The nearest competitor was MG Motor India, with a market share of just about 10 percent. Two years later, Tata’s dominance has been whittled away significantly, with its market share dropping to ...

JSW MG Motor India has launched the 2025 Astor in the Indian market. The latest iteration of the SUV comes at a starting price of Rs 9.99 lakh (ex-showroom) and has been rebranded as "the ...

with 10,698 units sold in South India alone. JSW MG Motor India has reported that nearly half of its electric vehicle (EV) sales in 2024 were driven by the South Indian market. According to data ...

MG Motor India is set to ace up its line-up with the premium MG Select dealerships coming in place. The carmaker took the veils of a few new vehicles at Bharat Mobility Global Expo 2025.

US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, it has since become a global blockbuster.